Addiction Treatment

Right now, about 30% of Americans treated for clinical depression don’t see any improvements. Not with therapy. Not after trying one medication, then another, then a third. Relief remains agonizingly out of reach. That’s why doctors, therapists, and Washington policymakers…

New York City.-based NYC Health + Hospitals/Jacobi unveiled a 15-piece art exhibit at its Comprehensive Addiction Treatment Center (CATC). The exhibit is intended to promote reflection and reduce stress for patients and staff. The exhibit — featuring works by Jim…

The anxiety among healthcare leaders is widespread. Sixty-six percent of healthcare finance leaders now name Medicaid cuts their top concern, according to Strata’s latest survey — ahead of labor costs, payer negotiations and everything else. HR 1 is projected to…

The American Hospital Association released new resources July 23 to help hospitals and health systems improve care transitions and long-term treatment engagement for patients with opioid use disorder and stimulant use disorder.  The Bridge to Care: Continuing the Momentum website…

Despite the Trump administration’s efforts to reduce federal funding for harm reduction initiatives, several Republican-led states have expanded support for programs aimed at reducing overdose deaths, according to a July 18 report from Politico. U.S. drug overdose deaths have fallen,…

Patient acuity is rising. Approximately 21.2 million adults have a co-occurring mental illness and substance use disorder, according to the Substance Abuse and Mental Health Services Administration’s “2024 National Survey on Drug Use and Health.”  As whole-person care continues to…

The Delaware Department of Health and Social Services, through its Division of Substance Abuse and Mental Health, introduced statewide guidance for treating opioid use disorder in emergency departments across the state.  Here are three things to know:

Maryland pharmacists will gain expanded authority to participate in opioid use disorder treatment under a new state law taking effect July 1. House Bill 838 eliminates the requirement that authorized prescribers submit prescriber-pharmacist agreements to the applicable health occupations board.…

Hospitalized patients with opioid use disorder who received higher doses of short-acting opioids were less likely to leave the hospital within 72 hours, according to a study published June 16 in JAMA Network Open.  Researchers from the University of California…

The FDA on June 16 approved Rextovy, a 4-milligram naloxone hydrochloride nasal spray, for over-the-counter use. The decision aligns with President Donald Trump’s federally coordinated effort to address the addiction and substance use crisis across the U.S., according to a…